Open AccessErythrocyte hemighosts in a patient with tumor lysis syndrome: One train may hide another
Author(s) -
Cabantous Pierre,
Daliphard Sylvie,
Bobée Victor
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3011
Subject(s) - tumor lysis syndrome , rasburicase , medicine , hyperuricemia , hematology , anemia , hemolysis , lysis , intensive care medicine , pathology , immunology , uric acid , chemotherapy
Rasburicase was introduced to treat hyperuricemia secondary to tumor lysis syndrome. Because of severe hemolytic anemia, a blood smear was requested and showed hemighosts, revealing G6PD deficiency. Erythrocyte morphology is a key tool in laboratory hematology.